List of Excipients in API RIVASTIGMINE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing RIVASTIGMINE
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Novartis Pharmaceuticals Corporation | EXELON | rivastigmine | 0078-0501 | .ALPHA.-TOCOPHEROL | |
Sandoz Inc | RIVASTIGMINE | rivastigmine | 0781-7304 | .ALPHA.-TOCOPHEROL | |
Rebel Distributors Corp | EXELON | rivastigmine | 21695-357 | ALPHA-TOCOPHEROL | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing RIVASTIGMINE
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 | COPOVIDONE K25-31 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 | D&C BLACK NO. 2 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 | DIMETHICONE 12500 |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for RIVASTIGMINE
Excipient focus: .ALPHA.-TOCOPHEROL
RIVASTIGMINE drug variants containing .ALPHA.-TOCOPHEROL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing .ALPHA.-TOCOPHEROL
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Northstar Rx LLC | rivastigmine | 16714-115 |
Rebel Distributors Corp | rivastigmine | 21695-357 |
>Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
RIVASTIGMINE drug variants containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | rivastigmine tartrate | 62756-145 |
American Health Packaging | rivastigmine tartrate | 68084-550 |
Carilion Materials Management | rivastigmine tartrate | 68151-4134 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: ALPHA-TOCOPHEROL
RIVASTIGMINE drug variants containing ALPHA-TOCOPHEROL
Company | Ingredient | NDC |
---|---|---|
Rebel Distributors Corp | rivastigmine | 21695-357 |
Physicians Total Care Inc | rivastigmine | 54868-6070 |
Amneal Pharmaceuticals LLC | rivastigmine | 65162-825 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing ALPHA-TOCOPHEROL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
RIVASTIGMINE drug variants containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | rivastigmine tartrate | 0904-7107 |
Sun Pharmaceutical Industries Inc | rivastigmine tartrate | 62756-145 |
Aurobindo Pharma Limited | rivastigmine tartrate | 65862-648 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
RIVASTIGMINE drug variants containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | rivastigmine tartrate | 62756-145 |
American Health Packaging | rivastigmine tartrate | 68084-550 |
Carilion Materials Management | rivastigmine tartrate | 68151-4134 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
RIVASTIGMINE drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | rivastigmine tartrate | 0904-6587 |
Major Pharmaceuticals | rivastigmine tartrate | 0904-7107 |
Ajanta Pharma Limited | rivastigmine tartrate | 27241-090 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
RIVASTIGMINE drug variants containing COPOVIDONE K25-31
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing COPOVIDONE K25-31
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Sandoz Inc | rivastigmine | 0781-7304 |
Northstar Rx LLC | rivastigmine | 16714-115 |
>Company | >Ingredient | >NDC |
Excipient focus: D&C BLACK NO. 2
RIVASTIGMINE drug variants containing D&C BLACK NO. 2
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing D&C BLACK NO. 2
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Sandoz Inc | rivastigmine | 0781-7304 |
Northstar Rx LLC | rivastigmine | 16714-115 |
>Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 28
RIVASTIGMINE drug variants containing D&C RED NO. 28
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | rivastigmine tartrate | 62756-145 |
American Health Packaging | rivastigmine tartrate | 68084-550 |
Carilion Materials Management | rivastigmine tartrate | 68151-4134 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing D&C RED NO. 28
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
RIVASTIGMINE drug variants containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | rivastigmine tartrate | 62756-145 |
McKesson Corporation dba SKY Packaging | rivastigmine tartrate | 63739-576 |
American Health Packaging | rivastigmine tartrate | 68084-550 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
RIVASTIGMINE drug variants containing DIMETHICONE
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals LLC | rivastigmine | 65162-825 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing DIMETHICONE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE 12500
RIVASTIGMINE drug variants containing DIMETHICONE 12500
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing DIMETHICONE 12500
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Sandoz Inc | rivastigmine | 0781-7304 |
Northstar Rx LLC | rivastigmine | 16714-115 |
>Company | >Ingredient | >NDC |
Excipient focus: DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
RIVASTIGMINE drug variants containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Sandoz Inc | rivastigmine | 0781-7304 |
Northstar Rx LLC | rivastigmine | 16714-115 |
>Company | >Ingredient | >NDC |
Excipient focus: DOCUSATE SODIUM
RIVASTIGMINE drug variants containing DOCUSATE SODIUM
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing DOCUSATE SODIUM
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Sandoz Inc | rivastigmine | 0781-7304 |
Northstar Rx LLC | rivastigmine | 16714-115 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
RIVASTIGMINE drug variants containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
McKesson Corporation dba SKY Packaging | rivastigmine tartrate | 63739-576 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
RIVASTIGMINE drug variants containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
McKesson Corporation dba SKY Packaging | rivastigmine tartrate | 63739-576 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
RIVASTIGMINE drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | rivastigmine tartrate | 54868-6145 |
McKesson Corporation dba SKY Packaging | rivastigmine tartrate | 63739-576 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
RIVASTIGMINE drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | rivastigmine tartrate | 54868-6145 |
Sun Pharmaceutical Industries Inc | rivastigmine tartrate | 62756-145 |
American Health Packaging | rivastigmine tartrate | 68084-550 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
RIVASTIGMINE drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Major Pharmaceuticals | rivastigmine tartrate | 0904-6587 |
Major Pharmaceuticals | rivastigmine tartrate | 0904-7107 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Sandoz Inc | rivastigmine | 0781-7304 |
Northstar Rx LLC | rivastigmine | 16714-115 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
RIVASTIGMINE drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Major Pharmaceuticals | rivastigmine tartrate | 0904-6587 |
Major Pharmaceuticals | rivastigmine tartrate | 0904-7107 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Sandoz Inc | rivastigmine | 0781-7304 |
Northstar Rx LLC | rivastigmine | 16714-115 |
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
RIVASTIGMINE drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | rivastigmine tartrate | 0904-7107 |
Ajanta Pharma Limited | rivastigmine tartrate | 27241-090 |
Dr Reddy's Laboratories Limited | rivastigmine tartrate | 55111-352 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
RIVASTIGMINE drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | rivastigmine tartrate | 0904-6587 |
Major Pharmaceuticals | rivastigmine tartrate | 0904-7107 |
Ajanta Pharma Limited | rivastigmine tartrate | 27241-090 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
RIVASTIGMINE drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | rivastigmine tartrate | 0904-6587 |
Alembic Pharmaceuticals Limited | rivastigmine tartrate | 46708-063 |
Breckenridge Pharmaceutical Inc | rivastigmine tartrate | 51991-793 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
RIVASTIGMINE drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | rivastigmine tartrate | 0904-7107 |
Dr Reddy's Laboratories Limited | rivastigmine tartrate | 55111-352 |
American Health Packaging | rivastigmine tartrate | 60687-777 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
RIVASTIGMINE drug variants containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Ajanta Pharma Limited | rivastigmine tartrate | 27241-090 |
Macleods Pharmaceuticals Limited | rivastigmine tartrate | 33342-089 |
Cadila Pharmaceuticals Limited | rivastigmine tartrate | 71209-012 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: INDIGOTINDISULFONATE SODIUM
RIVASTIGMINE drug variants containing INDIGOTINDISULFONATE SODIUM
Company | Ingredient | NDC |
---|---|---|
McKesson Corporation dba SKY Packaging | rivastigmine tartrate | 63739-576 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing INDIGOTINDISULFONATE SODIUM
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: LIGHT MINERAL OIL
RIVASTIGMINE drug variants containing LIGHT MINERAL OIL
Company | Ingredient | NDC |
---|---|---|
Northstar Rx LLC | rivastigmine | 16714-115 |
Zydus Lifesciences Limited | rivastigmine | 51956-0001 |
Zydus Pharmaceuticals USA Inc | rivastigmine | 70710-1196 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing LIGHT MINERAL OIL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
RIVASTIGMINE drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | rivastigmine tartrate | 0904-6587 |
Major Pharmaceuticals | rivastigmine tartrate | 0904-7107 |
Ajanta Pharma Limited | rivastigmine tartrate | 27241-090 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYISOBUTYLENE
RIVASTIGMINE drug variants containing POLYISOBUTYLENE
Company | Ingredient | NDC |
---|---|---|
Northstar Rx LLC | rivastigmine | 16714-115 |
Alvogen Inc | rivastigmine transdermal system | 47781-304 |
Zydus Lifesciences Limited | rivastigmine | 51956-0001 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing POLYISOBUTYLENE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYTETRAFLUOROETHYLENE
RIVASTIGMINE drug variants containing POLYTETRAFLUOROETHYLENE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing POLYTETRAFLUOROETHYLENE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Sandoz Inc | rivastigmine | 0781-7304 |
Northstar Rx LLC | rivastigmine | 16714-115 |
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
RIVASTIGMINE drug variants containing POTASSIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | rivastigmine tartrate | 0904-7107 |
Ajanta Pharma Limited | rivastigmine tartrate | 27241-090 |
Chartwell RX LLC | rivastigmine tartrate | 62135-900 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing POTASSIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
RIVASTIGMINE drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | rivastigmine tartrate | 0904-7107 |
Ajanta Pharma Limited | rivastigmine tartrate | 27241-090 |
Chartwell RX LLC | rivastigmine tartrate | 62135-900 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
RIVASTIGMINE drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | rivastigmine tartrate | 0904-7107 |
Ajanta Pharma Limited | rivastigmine tartrate | 27241-090 |
Chartwell RX LLC | rivastigmine tartrate | 62135-900 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
RIVASTIGMINE drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Northstar Rx LLC | rivastigmine | 16714-115 |
Zydus Lifesciences Limited | rivastigmine | 51956-0001 |
Zydus Pharmaceuticals USA Inc | rivastigmine | 70710-1196 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
RIVASTIGMINE drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | rivastigmine tartrate | 0904-7107 |
Macleods Pharmaceuticals Limited | rivastigmine tartrate | 33342-089 |
Aurobindo Pharma Limited | rivastigmine tartrate | 65862-648 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
RIVASTIGMINE drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | rivastigmine tartrate | 0904-6587 |
Major Pharmaceuticals | rivastigmine tartrate | 0904-7107 |
Ajanta Pharma Limited | rivastigmine tartrate | 27241-090 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Sandoz Inc | rivastigmine | 0781-7304 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER
RIVASTIGMINE drug variants containing TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | rivastigmine | 0378-9070 |
Amneal Pharmaceuticals LLC | rivastigmine | 65162-825 |
>Company | >Ingredient | >NDC |
RIVASTIGMINE drug variants not containing TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | rivastigmine | 0078-0501 |
Sandoz Inc | rivastigmine | 0781-7304 |
Northstar Rx LLC | rivastigmine | 16714-115 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.